Synthetic Biology Platforms Accelerate Biopharmaceutical R&D

 ·  1 min read

Biotechnology firms are leveraging computational protein design to optimize candidate therapeutic molecules prior to initiating clinical trial phases.

Pipeline Optimization
Automated screening pipelines have compressed early-stage molecule validation from years to months, sharply reducing preclinical research expenditure.